Skip to main content
Free shipping on orders over $49.00
Support: 1-808-301-6565
Sign In Cart
JAKAFI XR 33 mg/1 tablet, extended release by Incyte Corporation
Prescription only

JAKAFI XR

ruxolitinib

Listed by Incyte Corporation

Strength
33 mg/1
Form
Tablet, Extended Release
Route
Oral
Class
Janus Kinase Inhibitor; Kinase Inhibitor

What it contains

  • Ruxolitinib 33 mg/1

FDA record

Dosage form Tablet, Extended Release
Route Oral
Drug class Janus Kinase Inhibitor; Kinase Inhibitor
Approval route NDA — original brand approval
NDC code 50881-033
FDA application NDA217180
RxNorm concept 1193331
Package sizes listed 1
Marketed since May 2026

Other products containing Ruxolitinib

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

JAKAFI

ruxolitinib

Strength
10 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
25 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
15 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
5 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI

ruxolitinib

Strength
20 mg/1
Form
Tablet
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI XR

ruxolitinib

Strength
11 mg/1
Form
Tablet, Extended Release
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI XR

ruxolitinib

Strength
55 mg/1
Form
Tablet, Extended Release
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

JAKAFI XR

ruxolitinib

Strength
44 mg/1
Form
Tablet, Extended Release
Class
Janus Kinase Inhibitor; Kinase Inhibitor
Rx only

Incyte Corporation

$483.00 We supply Rutinib cream 1.5% 1 tube 30 g (different strength or form) View product

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.